Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:10:00
We are driven by the pursuit of safe and effective medical devices that improve the health and well-being of people|Marc Hedrick,President,Cytori Therapeutics Inc
00:10:00
Transformative Therapies for Autoimmune Diseases|Carl Magnus Hogerkorp,CEO,Cyxone
00:10:00
Our initial focus areas include contraception fertility and sexual and vaginal health|SABRINA MARTUCCI JOHNSON,President,Dare Bioscience Inc
00:10:00
Diamyd Medical develops therapies for type 1 diabetes|Anders EssenMoller,Chairman,Diamyd Medical
00:10:00
We believe the key to treating neurodegenerative disease is to intervene early|David Kalergis,CEO,Diffusion Pharmaceuticals Inc
00:10:00
Protect your future with geneType risk assessment|Simon Morriss,CEO,Genetic Technologies Ltd
00:10:00
CEDE Morning Chat with Ismael Clemente
00:10:00
Ismael Clemente Leads Merlin Properties: V Iberian REIT in Madrid, 2023
00:10:00
Ismael Clemente Leads Merlin Properties: V Iberian REIT in Madrid, 2023
00:10:00
Analyzing Business Horizons: A Conversation with Megaworld Corporation's Head of Data Analytics, Francis Adrian Viernes - ANC Special Report
00:10:00
Exploring Urban Horizons: A Conversation with Eng. Hamad Bin Ali Al Hedfa, CEO of Mazaya Qatar - Cityscape Qatar 2013
00:10:00
Behind the Helm: A Spotlight on Seraj Al Baker, Leading Mazaya Qatar as CEO
00:10:00
Unlocking Opportunities: Seraj Al Baker's Insights on Mazaya Qatar Real Estate | World Finance Exclusive
00:10:00
Cellmid develops innovative therapies and diagnostics for cancer inflammation and heart attack|MARIA HALASZ,CEO,Cellmid Ltd
00:10:00
Contribute to the development of innovative therapies for patients without existing or effective treatment|Cyrille Tupin,CEO,Cerenis Therapeutics Holding
00:10:00
Accelerating Drug Development Through Superior Innovative Solutions|Ronnie Morris, MD,Champions Oncology Inc
00:10:00
Biopharmaceutical company focused on the development and commercialization of firstinclass critical care products|Myron Holubiak,CEO,Citius Pharmaceuticals
00:10:00
Developing A New Class of Immunotherapies|Julie M Clifford,Vice President,Cleveland Biolabs Inc
00:10:00
SUPERIOR SAFETY PROFILE WITH MINIMAL SIDE EFFECTS|JOHN CAVAN,CEO,ContraVir Pharmaceuticals Inc
00:10:00
Based on proprietary heparin technology Corline Biomedical develops Renaparin to improve kidney transplantation|Henrik Nittmar, CEO,Corline Biomedical

© 2017 - Neuhu+